Poly Medicure Limited (BOM: 531768)
India
· Delayed Price · Currency is INR | Market Cap | 255.31B |
| Revenue (ttm) | 15.22B |
| Net Income (ttm) | 2.95B |
| Shares Out | 101.33M |
| EPS (ttm) | 30.63 |
| PE Ratio | 82.26 |
| Forward PE | 65.47 |
| Dividend | 3.00 (0.12%) |
| Ex-Dividend Date | Sep 19, 2024 |
| Volume | 3,698 |
| Average Volume | 5,872 |
| Open | 2,480.00 |
| Previous Close | 2,483.90 |
| Day's Range | 2,466.05 - 2,540.65 |
| 52-Week Range | 1,360.95 - 3,350.00 |
| Beta | 0.36 |
| RSI | 40.28 |
| Earnings Date | Oct 22, 2024 |
About Poly Medicure
Poly Medicure Limited manufactures and sells medical devices in India and internationally. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also... [Read more]
Financial Performance
In 2023, Poly Medicure's revenue was 13.76 billion, an increase of 23.36% compared to the previous year's 11.15 billion. Earnings were 2.58 billion, an increase of 44.05%.
Financial StatementsNews
Poly Medicure announces Joint Venture for solar power project
Poly Medicure Limited has entered into a joint venture agreement with AMPIN C&I Power Private Limited to establish a solar power project in Haryana, India. This initiative aims to supply power to Poly...
Top market losers today: ZF Commercial India plunges 12.85%, GE Vernova down 5.00%, Prestige Estates drops 3.59% in morning trade
In morning trade, at 9:58AM, the market witnessed significant losses across various sectors, with the following stocks leading the decliners: ZF Commercial India Ltd. tumbled 12.85% to ₹12,544.40, she...
Poly Medicure Q2 Results: Revenue surges 9.15% YoY to ₹420.01 crore, Net Profit surges 40.64% YoY
Poly Medicure has reported robust financial results for Q2 FY24, showcasing significant growth both year-on-year (YoY) and quarter-on-quarter (QoQ). The company’s consolidated revenue and net profit f...
Stock market update: Q2 FY25 results today for Sumitomo Chemical, Pfizer, Poly Medicure, Firstsource, Anant Raj, CAMS, Kalpatru, Railtel and more
A variety of companies across the chemical, pharmaceutical, healthcare, technology, and infrastructure sectors are set to release their Q2 FY25 earnings results today. Investors and analysts will focu...
Top gainers in today’s market: Aptus surges 9.20%, BSE up 7.80%, Poly Medicure jumps 6.24%, CDSL rises 5.26%
As of 12:33 PM, the stock market witnessed notable movements with several companies leading the charge. Among the top gainers, Aptus Value Housing Finance, BSE Limited, and Poly Medicure emerged as st...
Poly Medicure shares rise nearly 2% after raising ₹1,000 crore through QIP
Poly Medicure Ltd. saw its shares rise nearly 2% after the company successfully raised ₹1,000 crore through a Qualified Institutional Placement (QIP). The institutional share sale was completed on Thu...
Stock to watch today: Poly Medicure launches QIP to raise ₹1,000 crore
Poly Medicure has initiated a Qualified Institutional Placement (QIP) aiming to raise ₹1,000 crore, according to CNBC-TV18. This move is set to result in a 5.54% equity dilution based on the company’s...